Regeneron Pharmaceuticals Inc.
Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase[...]
Key data governance questions to ask when evaluating AI solutions for[...]
05/10/2024 | Press release | Distributed by Public on 05/10/2024 11:09
Please select the service you want to use:
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact